Piramal Pharma unit infuses ₹1,626 crore into PPL Pharma via preference shares
The total investment aggregates to $190.3 million (₹1,626.49 crore). PPL Pharma Inc. is a step-down wholly owned subsidiary of the company. Shares of Piramal Pharma Ltd ended at ₹191.80, down by ₹2.75, or 1.41%, on the BSE.

What's Your Reaction?






